In the course of screening for microorganisms producing novel antibiotics, a new streptomycete was discovered which produced a water-soluble basic antibiotic of considerably greater lipophilicity than most typical aminoglycoside or aminocyclitol antibiotics''. The antibiotic also showed activity against several aminoglycoside-resistant bacteria.
As a result, the producing organism was fermented on a multiliter scale for isolation and structure elucidation. Klebsiella pneumoniae ATCC 8045 was chosen as the assay organism.
Isolation
The antibiotic activity could be absorbed from the clear filtered fermentation broth, adjusted with mineral acid to pH 7, onto Amberlite IRC-84 resin in the ammonium form. Considerable purification was obtained by eluting the activity from the resin with a gradient eluant from water to 0.1 N ammonium hydroxide. Active fractions were neutralized with dilute acetic acid and lyophilized. A similar chromatography over carboxymethyl Sepharose resulted in the separation of two active components.
The first eluate contained the major activity and was further purified by chromatography over Fractogel, conversion to the sulfate salt and a final chromatography over octadecyl-capped silica gel to yield a pure antibiotic, which we have subsequently named spenolimycin. The minor bioactive component, eluted from the carboxymethyl Sepharose after spenolimycin was identified as spectinomycin by comparison of its 'H NMR spectrum with that of an authentic sample.
Structure Determination
The mass spectrum of spenolimycin was measured with both fast atom bombardment (FAB) and electron impact (EI) ionizations. The FAB positive ion spectrum shows an MH+ peak at 347 daltons and an MNa+ peak at 369 daltons. The MH+ peak was mass-matched at 347.1847 (theory 347.1818) corresponding to C15H26N2O7 for the molecular formula, and this was supported by mass matching of the molecular ion MT• at 346.1741 (theory 346.1740) in the electron impact spectrum. A major peak at 141 daltons in the FAB spectrum was mass matched at 141.0532 and assigned the molecular formula C7H9O3
(theory 141.0552). A major peak at 207 daltons corresponds to a protonated cyclitol portion with the formula C8H19N2O4+. OF ANTIBIOTICS DEC. 1984 The 'H NMR spectrum of spenolimycin measured in deuterium oxide in a 2D correlated spectroscopy (COSY) experiment is shown in Fig. 1 . This spectrum was measured at ambient temperature at 360 MHz.
The COSY results indicate a definite coupling for a peak hidden under the large HOD peak at 5 4.9. In a similar spectrum measured at 300 MHz, the HOD peak was displaced to reveal a Only two naturally-occurring antibiotics are known to contain actinamine as a structural moiety; spectinomycin2 1) (1) and 3'-R-dihydrospectinomycin5,6) (2).* Clearly, from its 1H NMR spectrum, spenolimycin is different from each of these antibiotics. However, not only does the presence of actinamine suggest a structural relationship but other aspects of the 'H NMR spectrum of spenolimycin resemble those of the spectinomycins. A singlet at a 4.98 is characteristic of the anomeric proton of these antibiotics where C-2' of the sugar is involved in a stable quaternary hemiketal. The spectrum also These observations are consistent with two possible structures, 3 and 4.
The 1,C NMR spectrum of spenolimycin is listed in Table I bore spectrometer in D,O solutions with TSP as an external standard (d 0 ppm) or in CDCl3 solutions with TMS as an internal standard. The 2D proton-carbon chemical shift correlation (CSCM) experiment was perfomed on the Nicolet WB-360 spectrometer using a 5 mm C-13 probe and a model 1280 computer. The CSCM pulse sequence employed for the experiment was essentially that of FREEMAN10) modified to deliver a composite 180° pulse11). Ninety degree pulse widths of 9 pseconds for carbon and 25 pseconds for hydrogen were used. Fixed delays around the acquisition pulse (d, and 4.2) were set to 3.3 and 1.7 mseconds, respectively, with phase-cycling to provide the equivalent of quadrature data in both dimensions. The COSY pulse sequence used a 90° pulse of 12 aseconds. Mass spectra were determined on a Kratos MS-50 spectrometer. High resolution measurements were made with 10,000 resolving power. UV spectra were determined with a Cary 219 spectrophotometer. IR spectra were measured using a Perkin Elmer Model 521 grating spectrometer. Optical rotations were measured in 1 dm tubes using a Perkin Elmer Model 241 polarimeter.
Isolation of Spenolimycin
The fermentation broth of Streptomyces gilvospiralis sp. nov. was adjusted to pH 7 with dilute HCl and filtered through Celite. The clear filtrate (94 liters) was charged onto a column (1.5 liters bed volume) of Amberlite IRC-84 (NH4+ form), and the column was eluted with a gradient from H2O (3 liters) to 0.1 M ammonium hydroxide solution (6 liters). Fractions active against Klebsiella pneumoniae ATCC 8045 were combined, neutralized with dilute acetic acid and lyophilized. The white, solid residue was digested in H2O and chromatographed over a column (2.5 x 90 cm) of CM-Sepharose (Pharmacia) in the ammonium form. Antibiotic activity was eluted with a gradient from H2O (2 liters) to 0.1 N ammonium hydroxide solution (3 liters). Two major bioactive bands were eluted. The fractions from each band were combined, neutralized with acetic acid and lyophilized to yield crude spenolimycin 3.9 g and spectinomycin 1.17 g. The spenolimycin was further purified by chromatography of 1 g portions over a column (2.5 x 90 cm) of Fractogel in 0.05 M pH 6.9 ammonium acetate solution. Active fractions from four columns were pooled, lyophilized and converted to the sulfate salt with dilute sulfuric acid. The sulfate salt was further purified by chromatography over a column (1. Reduction of Spenolimycin Spenolimycin sulfate (26 mg) in H2O (2 ml) was passed through a column (2 ml) of Amberlite AG1 X2 (OH-).
The eluate was lyophilized and the spenolimycin free base obtained was digested in MeOH (10 ml). The solution was shaken over 5 % rhodium on carbon (20 mg) under 3 atmospheres of hydrogen for 20 hours. Catalyst was filtered off and a TLC of the filtrate indicated multiple ninhydrin positive spots of similar RE Solvent was removed and the residue was digested in H2O (1 ml) and acetonitrile (I ml) and treated with triethylamine (0.02 ml). The mixture was cooled to -5°C and N-(benzoyloxycarbonyloxy)succinimide (37 mg) was added. The mixture was stirred and allowed to come to room temperature. After being stirred for 5 hours the mixture was diluted with H,O (15 ml) and extracted with CHCl3 (4 x 10 ml). The combined chloroform extracts were concentrated to an oil (28.3 mg). This was chromatographed over a column (0.9 x 30 cm) of Woelm, Kiesel Gel G 32-63 ,um (about 7.6 g) packed and loaded in benzene and eluted with a mixture of benzene (460 ml) and isopropanol (40 ml). Approximately 2 ml fractions were collected. This application claims an antibiotic, acmimycin, of the same structure as that described here for spenolimycin.
Although the stereochemistry for acmimycin is not defined in this patent and some minor differences in quoted physical constants exist, the close correspondence of the carbon magnetic resonance data suggest that acmimycin and spenolimycin are the same antibiotic.
The producing organisms Streptomyces gilvospiralis (strain AB634D-177) and Streptomyces strain AC 4559 clearly differ from one another based on their carbon source utilization patterns and on the color of their aerial mycelium.
S. gilvospiralis can assimilate arabinose, fructose, mannitol, raffinose, and rhamnose while strain AC 4559 cannot. The aerial mycelium of S. gilvospiralis is yellowish white to pale yellow on most media (ISP 2, 3, 4 and 5 and nutrient agars); strain AC 4559 is white to dusty aqua on the same media.
